CODY TURNER: Open Payments
NPI 1578279162 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$875 in 47 payments from 15 companies in 2025. Trend: 2023 $385 · 2024 $855 · 2025 $875
Food & beverage: $875
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $264 |
| Novo Nordisk Inc | 12 | $141 |
| ABBVIE INC. | 4 | $76 |
| PFIZER INC. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Braeburn Inc. | 2 | $40 |
| Amgen Inc. | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Exact Sciences Corporation | 2 | $35 |
| Merck Sharp & Dohme LLC | 2 | $31 |
Products named: BREZTRI, FARXIGA, Wegovy, CAPLYTA, AIRSUPRA, Ozempic, BRIXADI, Rybelsus.
Industry payments across SC — which companies pay providers there.
